Eversept Partners’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-138,489
Closed -$7.34M 81
2024
Q2
$7.34M Buy
138,489
+115,671
+507% +$6.13M 0.5% 33
2024
Q1
$1.87M Buy
+22,818
New +$1.87M 0.12% 60
2018
Q4
Sell
-25,000
Closed -$436K 64
2018
Q3
$436K Buy
+25,000
New +$436K 0.19% 51